La. Is Latest State To Demand Causation For Medicaid Fraud
February 7, 2014, 4:31 PM EST
Law360, New York (February 7, 2014, 4:31 PM EST) -- In a split decision, the Louisiana Supreme Court recently stripped the state of Louisiana of a $258 million jury award against Janssen Pharmaceutica Inc. and Johnson & Johnson in connection with its marketing of the anti-psychotic drug, Risperdal, concluding that the state failed to present evidence establishing a causal link between the defendants’ alleged bad acts and the submission of false claims for payment under Louisiana’s Medicaid fraud/false claims statute.
This decision represents the most recent example of a state appellate court requiring a state, which...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.